We are live on ! Find out more
CT

Cambridge Trust Portfolio holdings

AUM $2.64B
1-Year Est. Return 28.73%
This Fund
S&P 500
This Quarter Est. Return
+3.33%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$1.42B
AUM Growth
+$53.3M
Cap. Flow
+$29.9M
Cap. Flow %
2.1%
Top 10 Hldgs %
26.02%
Holding
276
New
21
Increased
128
Reduced
73
Closed
13

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$6.96M
2
MRK icon
Merck
MRK
+$6.29M
3
UNH icon
UnitedHealth
UNH
+$5.85M
4
AMZN icon
Amazon
AMZN
+$5.11M
5
META icon
Meta Platforms (Facebook)
META
+$4.86M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$11.9M
2
CAH icon
Cardinal Health
CAH
+$9.07M
3
T icon
AT&T
T
+$3.98M
4
MDT icon
Medtronic
MDT
+$3.36M
5
EL icon
Estee Lauder
EL
+$2.92M

Sector Composition

Rank Sector Weight
1 Financials 17.84%
2 Healthcare 14.41%
3 Technology 13.82%
4 Industrials 11.14%
5 Energy 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APH icon
176
Amphenol
APH
$194B
$538K 0.04%
32,000
IVW icon
177
iShares S&P 500 Growth ETF
IVW
$76.8B
$522K 0.04%
17,140
+2,252
+15% +$68K
A icon
178
Agilent Technologies
A
$43.4B
$517K 0.04%
11,348
+1,831
+19% +$83.1K
COST icon
179
Costco
COST
$419B
$487K 0.03%
3,044
-23
-0.7% -$3.51K
FMX icon
180
Fomento Económico Mexicano
FMX
$40.9B
$487K 0.03%
6,390
-274
-4% -$23.5K
MLM icon
181
Martin Marietta Materials
MLM
$37.7B
$480K 0.03%
2,165
+11
+0.5% +$2.26K
CWI icon
182
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.89B
$470K 0.03%
22,392
+2,965
+15% +$62.6K
GD icon
183
General Dynamics
GD
$103B
$470K 0.03%
2,720
+1,225
+82% +$200K
SYY icon
184
Sysco
SYY
$39.3B
$467K 0.03%
8,429
+3,300
+64% +$171K
AMLP icon
185
Alerian MLP ETF
AMLP
$13.4B
$460K 0.03%
7,307
UL icon
186
Unilever
UL
$140B
$457K 0.03%
9,990
+1,666
+20% +$77.7K
CTAS icon
187
Cintas
CTAS
$81.7B
$447K 0.03%
15,460
+2,040
+15% +$57.3K
IWM icon
188
iShares Russell 2000 ETF
IWM
$80.8B
$444K 0.03%
3,292
+118
+4% +$15.1K
SO icon
189
Southern Company
SO
$102B
$436K 0.03%
8,859
LLY icon
190
Eli Lilly
LLY
$1.05T
$426K 0.03%
5,790
+11
+0.2% +$819
SAIC icon
191
Saic
SAIC
$5.33B
$424K 0.03%
5,000
MRSH
192
Marsh
MRSH
$91.9B
$422K 0.03%
6,245
+675
+12% +$45.3K
GWW icon
193
W.W. Grainger
GWW
$61.5B
$418K 0.03%
1,800
TROW icon
194
T. Rowe Price
TROW
$23.7B
$411K 0.03%
5,460
-360
-6% -$25.5K
NCLH icon
195
Norwegian Cruise Line
NCLH
$7.65B
$406K 0.03%
9,551
+4,071
+74% +$163K
IAU icon
196
iShares Gold Trust
IAU
$66.1B
0
RRC icon
197
Range Resources
RRC
$9.69B
$402K 0.03%
11,712
+293
+3% +$10.5K
DE icon
198
Deere & Co
DE
$170B
$386K 0.03%
3,749
+100
+3% +$9.4K
AET
199
DELISTED
Aetna Inc
AET
$384K 0.03%
3,097
-110
-3% -$13.2K
TMP icon
200
Tompkins Financial
TMP
$1.41B
$379K 0.03%
4,005
-38
-0.9% -$3.18K

Similar funds

Cambridge Trust's Q4 2016 Portfolio in Review

As of Q4 2016, Cambridge Trust held 276 positions worth $1.42B, up 3.9% from $1.37B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Cambridge Trust's Q4 2016 filing shows 21 new, 128 increased, 73 reduced and 13 closed positions. Its largest new stake was State Street Consumer Staples Select Sector SPDR ETF: 38,120 shares worth $1.97M. The largest sale was Novartis, an estimated $11.9M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

  • Cambridge Trust's largest Q4 2016 buy was State Street Consumer Staples Select Sector SPDR ETF: 38,120 shares worth $1.97M.
  • Cambridge Trust added most to Celgene Corp in Q4 2016, an estimated $6.96M increase.
  • Cambridge Trust's biggest Q4 2016 reduction was Novartis, cutting an estimated $11.9M.
  • Cambridge Trust fully exited Cardinal Health in Q4 2016, selling an estimated $9.07M.
  • Cambridge Trust's ten largest holdings make up 26% of its $1.42B portfolio in Q4 2016.
  • Cambridge Trust opened 21 new positions and closed 13 in Q4 2016.
  • Cambridge Trust's portfolio value rose 3.9% quarter-over-quarter to $1.42B.

Based on Cambridge Trust's 13F filing for Q4 2016, filed 3 Feb 2017.